for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Top News

Breakingviews: Elan deal's tax zeal

Posted

July 29 - Jeffrey Goldfarb talks to Rob Cyran about the dangers of Perrigo's seemingly tax-motivated $8.6 billion acquisition of Irish biotech Elan.

Top News

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up